GIP receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-04-25. Numbers and descriptions here follow the published literature rather than marketing material.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
| Property | Value | Notes |
|---|---|---|
| Molecule class | Synthetic peptide | Engineered triple receptor agonist |
| Molecular weight | Approximately 4731 Da | Reported value; depends on form |
| Receptor targets | GLP-1, GIP, glucagon | Simultaneous activation |
| Development code | LY3437943 | Internal company designation |
| Current status | Investigational | No approved indication reported |
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
== W == Johannes Diderik van der Waals (1837–1923), Dutch physicist Sir James Walker (1863–1935), Scottish physical chemist John E. Walker (born 1941), British chemist, 1997 Nobel Prize in Chemistry Otto Wallach (1847–1931), German chemist, 1910 Nobel Prize in Chemistry John Warner (born 1962), American chemist, 2014 Perkin Medal, one of the "founders" of green chemistry Alfred Werner (1866–1919), Swiss chemist, 1913 Nobel Prize in Chemistry Thomas Summers West (1927–2010), British analytical chemist Peter Jaffrey Wheatley (1921–1997), English chemist Chaim Weizmann (1874–1952), Russian chemist, developed the ABE-process George M. Whitesides (born 1939), American chemist John Rex Whinfield (1901–1966), British chemist, discovered polyester fibres Otto Wichterle (1913–1998), Czech chemist, known for inventing modern contact lenses Heinrich Otto Wieland (1877–1957), German chemist 1927 Nobel Prize in Chemistry Julius Wilbrand (1839–1906), German chemist, inventor of TNT Harvey W.
The consequence of a broken ligament can be instability of the joint. Not all broken ligaments need surgery, but, if surgery is needed to stabilise the joint, the broken ligament can be repaired. Scar tissue may prevent this. If it is not possible to fix the broken ligament, other procedures such as the Brunelli procedure can correct the instability. Instability of a joint can over time lead to wear of the cartilage and eventually to osteoarthritis.
=== Microscopic characteristics === In deposit, the spores are a deep reddish purple-brown color. The use of an optical microscope can reveal further details: the spores are oblong when seen in side view, and oblong to oval in frontal view, with dimensions of 10.5–15 by 6.5–8.5 μm. The basidia (spore bearing cells of the hymenium), are 20–31 by 5–9 μm, four-spored, and have clamps at their bases; there are no basidia found on the sterile gill edge. The cheilocystidia (cystidia on the gill edge) measure 15–30 by 4–7 μm, and are flask-shaped with long thin necks that are 1–3.5 μm wide. P. semilanceata does not have pleurocystidia (cystidia on the gill face). The cap cuticle is up to 90 μm thick, and is made of a tissue layer called an ixocutis—a gelatinized layer of hyphae lying parallel to the cap surface. The hyphae comprising the ixocutis are cylindrical, hyaline, and 1–3.5 μm wide. Immediately under the cap cuticle is the subpellis, made of hyphae that are 4–12 μm wide with yellowish-brown encrusted walls. There are clamp connections present in the hyphae of all tissues.
== Molecules == The following tables list molecules that have been detected in the interstellar medium or circumstellar matter, grouped by the number of component atoms. Neutral molecules and their molecular ions are listed in separate columns; if there is no entry in the molecule column, only the ionized form has been detected. Designations (names of molecules) are those used in the scientific literature describing the detection; if none was given that field is left empty. Mass is listed in daltons. Deuterated molecules, which contain at least one deuterium (2H) atom, have slightly different masses and are listed in a separate table. The total number of unique species, including distinct ionization states, is indicated in each section header. Most of the molecules detected so far are organic. The only detected inorganic molecule with five or more atoms is SiH4. Molecules larger than that all have at least one carbon atom, with no N−N or O−O bonds.
Sources: en.wikipedia.org
==== Torres Strait ==== The mummies of the Torres Strait have a considerably higher level of preservation technique as well as creativity compared to those found on Australia. The process began with removal of viscera, after which the bodies were set in a seated position on a platform and either left to dry in the sun or smoked over a fire in order to aid in desiccation. In the case of smoking, some tribes would collect the fat that drained from the body to mix with ocher to create red paint that would then be smeared back on the skin of the mummy. The mummies remained on the platforms, decorated with the clothing and jewelry they wore in life, before being buried.
Reactive hypoglycemia, postprandial hypoglycemia, or sugar crash is symptomatic hypoglycemia occurring within four hours after a high-carbohydrate meal in people with and without diabetes. The term is not necessarily a diagnosis since it requires an evaluation to determine the cause of the hypoglycemia. The condition is related to homeostatic systems used by the body to control the blood sugar level. It is described as a sense of tiredness, lethargy, irritation, or hangover, although the effects can be lessened if a lot of physical activity is undertaken in the first few hours after food consumption. The alleged mechanism for the feeling of a crash is correlated with an abnormally rapid rise in blood glucose after eating. This normally leads to insulin secretion (known as an insulin spike), which in turn initiates rapid glucose uptake by tissues, either storing it as glycogen or fat, or using it for energy production. The consequent fall in blood glucose is indicated as the reason for the "sugar crash". Another cause might be hysteresis effect of insulin action, i.e., the effect of insulin is still prominent even if both plasma glucose and insulin levels were already low, causing a plasma glucose level eventually much lower than the baseline level. Sugar crashes are not to be confused with the after-effects of consuming large amounts of protein, which produces fatigue akin to a sugar crash, but are instead the result of the body prioritising the digestion of ingested food.
However, treatment of women with ketoconazole (a strong CYP3A4 inhibitor) had minimal effects on progesterone levels, producing only a slight and non-significant increase, suggesting that cytochrome P450 enzymes play only a small role in progesterone metabolism.
The technique was first described by Semisotnov et al. (1991) using 1,8-ANS and quartz cuvettes. 3 Dimensional Pharmaceuticals were the first to describe a high-throughput version using a plate reader and Wyeth Research published a variation of the method with SYPRO Orange instead of 1,8-ANS. SYPRO Orange has an excitation/emission wavelength profile compatible with qPCR machines which are almost ubiquitous in institutions that perform molecular biology research. The name differential scanning fluorimetry (DSF) was introduced later but Thermofluor is preferable as Thermofluor is no longer trademarked and differential scanning fluorimetry is easily confused with differential scanning calorimetry. SYPRO Orange binds nonspecifically to hydrophobic surfaces, and water strongly quenches its fluorescence. When the protein unfolds, the exposed hydrophobic surfaces bind the dye, resulting in an increase in fluorescence by excluding water. Detergent micelles will also bind the dye and increase background noise dramatically. This effect is lessened by switching to the dye ANS; however, this reagent requires UV excitation. The stability curve and its midpoint value (melting temperature, Tm also known as the temperature of hydrophobic exposure, Th) are obtained by gradually increasing the temperature to unfold the protein and measuring the fluorescence at each point. Curves are measured for protein only and protein + ligand, and ΔTm is calculated.
==== Effectors ==== Pseudomonas syringae isolates carry a range of virulence factors called type III secretion system (T3SS) effector proteins. These proteins primarily function to cause disease symptoms and manipulate the host's immune response to facilitate infection. The major family of T3SS effectors in P. syringae is the hrp gene cluster, coding for the Hrp secretion apparatus.
Sources: en.wikipedia.org
In December 2021, Collins took part in a debate at the Oxford Union which was part of an advertising campaign for Sainsbury's. She argued that modern and alternative dishes should be served on Christmas Day as opposed to traditional Christmas food and stated that younger generations such as Gen Z would prefer unconventional dishes, endorsing the supermarket's festive food selection. Collins won the debate and said she "had a brilliant time debating at the Oxford Union, it was an absolute dream come true for me", adding that "We should embrace the newness, new taste, new traditions." On 8 and 9 December, Collins took part in "On Trend", a shopping experience broadcast live on TikTok. As part of the two-day event, Collins featured alongside influencers and content creators to promote products that viewers could purchase. In May 2022, Collins announced her collaboration with snack food manufacturer Walkers as part of their "Crisp In or Crisp Out" campaign. Collins featured in an advert alongside Ed Balls, Nigella Lawson, Gordon Ramsay and Fred Sirieix with Collins and Lawson arguing to "keep crisps in" sandwiches. On 19 June, Collins visited the town of Sandwich in Kent where she debated against Sirieix, who was canvassing to "keep crisps out". The residents of Sandwich then cast their votes on whether crisps should be kept in or out, with the majority choosing the former, resulting in Collins winning the debate and being crowned "President of Sandwich". In July 2022, Collins collaborated with the freemium online board and card game Bingo Blitz.
==== United States ==== Gabapentin is not a controlled substance under the federal Controlled Substances Act. Effective in July 2017, Kentucky classified gabapentin as a Schedule V controlled substance statewide. Gabapentin is a schedule V drug in other states such as West Virginia, Tennessee, Alabama, Utah, and Virginia.
Thiamine was the first of the water-soluble vitamins to be isolated. The earliest observations in humans and in chickens had shown that diets of primarily polished white rice caused beriberi, but did not attribute it to the absence of a previously unknown essential nutrient. In 1884, Takaki Kanehiro, a surgeon general in the Imperial Japanese Navy, rejected the previous germ theory for beriberi and suggested instead that the disease was due to insufficiencies in the diet. Switching diets on a navy ship, he discovered that replacing a diet of white rice only with one also containing barley, meat, milk, bread, and vegetables, nearly eliminated beriberi on a nine-month sea voyage. However, Takaki had added many foods to the successful diet and he incorrectly attributed the benefit to increased protein intake, as vitamins were unknown at the time. The Navy was not convinced of the need for such an expensive program of dietary improvement, and many men continued to die of beriberi, even during the Russo-Japanese War of 1904–05. Not until 1905, after the anti-beriberi factor had been discovered in rice bran (removed by polishing into white rice) and in barley bran, was Takaki's experiment rewarded. He was made a baron in the Japanese peerage system, after which he was affectionately called "Barley Baron". The specific connection to grain was made in 1897 by Christiaan Eijkman, a military doctor in the Dutch East Indies, who discovered that fowl fed on a diet of cooked, polished rice developed paralysis that could be reversed by discontinuing rice polishing.
provide an easy-to-use environment for individual application scientists themselves to create their own workflows, provide interactive tools for the scientists enabling them to execute their workflows and view their results in real-time, simplify the process of sharing and reusing workflows between the scientists, and enable scientists to track the provenance of the workflow execution results and the workflow creation steps. Some of the platforms giving this service: Galaxy, Kepler, Taverna, UGENE, Anduril, HIVE.
Sources: en.wikipedia.org
Retatrutide is an investigational peptide that activates the GLP-1, GIP, and glucagon receptors at the same time. It is being studied for obesity and type 2 diabetes and has not been approved for clinical use. The internal code LY3437943 refers to the same molecule.
Most approved incretin therapies target one or two receptors, while retatrutide engages three. The addition of glucagon receptor activity is intended to raise energy expenditure. This broader mechanism is the subject of ongoing research rather than established practice.
No regulatory agency has approved retatrutide for any indication as of available public information. Development remains in later-stage trials. Availability claims found online should be treated as unverified.
It is an investigational peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. It is being studied mainly for obesity and type 2 diabetes, and it is not approved for any clinical use. Published information comes from controlled trials rather than from general practice.